Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith S Currier

Showing results (171-180 of 298) with videos related to

Pageof 30
Sort By:
Metabolomics : Official Journal of the Metabolomic Society|October 25, 2023
Metabolomic profiling of preterm birth in pregnant women living with HIVNicole H Tobin, Aisling Murphy, Fan Li, et al.
The Journal of Infectious Diseases|December 16, 2003
Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletionHoward M Lederman, Paige L Williams, Julia W Wu, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Statistical Challenges when Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical TrialsCarlee B Moser, Kara W Chew, Mark J Giganti, et al.
The Pediatric Infectious Disease Journal|November 12, 2020
Maternal HBV Viremia and Association With Adverse Infant Outcomes in Women Living With HIV and HBVDebika Bhattacharya, Rong Guo, Chi-Hong Tseng, et al.
AIDS (London, England)|November 7, 2015
Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recoveryAnthony R Cillo, Benedict B Hilldorfer, Christina M Lalama, et al.
The Journal of Infectious Diseases|October 14, 2024
Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled TrialKara W Chew, Brooke McGinley, Carlee Moser, et al.
Eclinicalmedicine|September 10, 2024
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trialTeresa H Evering, Carlee Moser, Nikolaus Jilg, et al.
AIDS (London, England)|April 26, 2019
Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding womenPamela M Murnane, Peter Bacchetti, Judith S Currier, et al.
AIDS (London, England)|October 4, 2012
Characterization of HIV-HBV coinfection in a multinational HIV-infected cohortChloe L Thio, Laura Smeaton, Melissa Saulynas, et al.
The Journal of Infectious Diseases|November 18, 2021
COVID-19 Vaccination Rates in a Global HIV CohortEvelynne S Fulda, Kathleen V Fitch, Edgar T Overton, et al.
Pageof 30

Showing results (171-180 of 298) with videos related to

Sort By:
Pageof 30
Metabolomics : Official Journal of the Metabolomic Society|October 25, 2023
Metabolomic profiling of preterm birth in pregnant women living with HIVNicole H Tobin, Aisling Murphy, Fan Li, et al.
The Journal of Infectious Diseases|December 16, 2003
Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletionHoward M Lederman, Paige L Williams, Julia W Wu, et al.
Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
Statistical Challenges when Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical TrialsCarlee B Moser, Kara W Chew, Mark J Giganti, et al.
The Pediatric Infectious Disease Journal|November 12, 2020
Maternal HBV Viremia and Association With Adverse Infant Outcomes in Women Living With HIV and HBVDebika Bhattacharya, Rong Guo, Chi-Hong Tseng, et al.
AIDS (London, England)|November 7, 2015
Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recoveryAnthony R Cillo, Benedict B Hilldorfer, Christina M Lalama, et al.
The Journal of Infectious Diseases|October 14, 2024
Viral and Symptom Rebound Following Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Therapy in a Randomized Placebo-Controlled TrialKara W Chew, Brooke McGinley, Carlee Moser, et al.
Eclinicalmedicine|September 10, 2024
Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trialTeresa H Evering, Carlee Moser, Nikolaus Jilg, et al.
AIDS (London, England)|April 26, 2019
Tenofovir concentrations in hair strongly predict virologic suppression in breastfeeding womenPamela M Murnane, Peter Bacchetti, Judith S Currier, et al.
AIDS (London, England)|October 4, 2012
Characterization of HIV-HBV coinfection in a multinational HIV-infected cohortChloe L Thio, Laura Smeaton, Melissa Saulynas, et al.
The Journal of Infectious Diseases|November 18, 2021
COVID-19 Vaccination Rates in a Global HIV CohortEvelynne S Fulda, Kathleen V Fitch, Edgar T Overton, et al.
Pageof 30